nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—CYP3A4—Everolimus—kidney cancer	0.204	0.26	CbGbCtD
Adinazolam—CYP3A4—Temsirolimus—kidney cancer	0.138	0.176	CbGbCtD
Adinazolam—CYP2C19—Sorafenib—kidney cancer	0.087	0.111	CbGbCtD
Adinazolam—CYP3A4—Pazopanib—kidney cancer	0.0725	0.0923	CbGbCtD
Adinazolam—CYP3A4—Erlotinib—kidney cancer	0.0517	0.0659	CbGbCtD
Adinazolam—CYP3A4—Paclitaxel—kidney cancer	0.0474	0.0603	CbGbCtD
Adinazolam—CYP3A4—Sorafenib—kidney cancer	0.0421	0.0536	CbGbCtD
Adinazolam—CYP3A4—Vinblastine—kidney cancer	0.0415	0.0529	CbGbCtD
Adinazolam—CYP3A4—Vincristine—kidney cancer	0.0408	0.052	CbGbCtD
Adinazolam—CYP3A4—Sunitinib—kidney cancer	0.0341	0.0434	CbGbCtD
Adinazolam—CYP3A4—Doxorubicin—kidney cancer	0.0255	0.0325	CbGbCtD
Adinazolam—Clomipramine—GSTP1—kidney cancer	0.00258	0.228	CrCbGaD
Adinazolam—Ketazolam—ABCB1—kidney cancer	0.00124	0.11	CrCbGaD
Adinazolam—Chlorpromazine—BCHE—kidney cancer	0.00122	0.107	CrCbGaD
Adinazolam—Diazepam—PTGS1—kidney cancer	0.00106	0.0932	CrCbGaD
Adinazolam—Clobazam—ABCB1—kidney cancer	0.000879	0.0776	CrCbGaD
Adinazolam—Nitrazepam—ABCB1—kidney cancer	0.000726	0.0642	CrCbGaD
Adinazolam—Clomipramine—ABCB1—kidney cancer	0.000695	0.0614	CrCbGaD
Adinazolam—Chlorprothixene—ABCB1—kidney cancer	0.000692	0.0611	CrCbGaD
Adinazolam—Flurazepam—ABCB1—kidney cancer	0.000646	0.057	CrCbGaD
Adinazolam—Midazolam—ABCB1—kidney cancer	0.000599	0.0529	CrCbGaD
Adinazolam—Diazepam—ABCB1—kidney cancer	0.000513	0.0453	CrCbGaD
Adinazolam—Chlorpromazine—ABCB1—kidney cancer	0.000477	0.0421	CrCbGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000262	0.00129	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000257	0.00126	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—RAF1—kidney cancer	0.000256	0.00126	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—RELA—kidney cancer	0.000255	0.00125	CbGpPWpGaD
Adinazolam—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000255	0.00125	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000253	0.00124	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000251	0.00123	CbGpPWpGaD
Adinazolam—GABRB2—Ion channel transport—RAF1—kidney cancer	0.00025	0.00123	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MTOR—kidney cancer	0.00025	0.00123	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000247	0.00122	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—PTGS1—kidney cancer	0.000247	0.00122	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000246	0.00121	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—RAF1—kidney cancer	0.000245	0.0012	CbGpPWpGaD
Adinazolam—GABRA5—Ion channel transport—RAF1—kidney cancer	0.000243	0.00119	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000241	0.00119	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.00024	0.00118	CbGpPWpGaD
Adinazolam—GABRA3—Ion channel transport—RAF1—kidney cancer	0.000239	0.00117	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000237	0.00117	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000236	0.00116	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000236	0.00116	CbGpPWpGaD
Adinazolam—GABRA2—Ion channel transport—RAF1—kidney cancer	0.000234	0.00115	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000234	0.00115	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—RAF1—kidney cancer	0.000234	0.00115	CbGpPWpGaD
Adinazolam—GABRB3—Ion channel transport—RAF1—kidney cancer	0.000233	0.00115	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000233	0.00114	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000232	0.00114	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000231	0.00114	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000231	0.00114	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—BRAF—kidney cancer	0.00023	0.00113	CbGpPWpGaD
Adinazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000229	0.00113	CbGpPWpGaD
Adinazolam—GABRG2—Ion channel transport—RAF1—kidney cancer	0.000229	0.00112	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000228	0.00112	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—BRAF—kidney cancer	0.000227	0.00112	CbGpPWpGaD
Adinazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000226	0.00111	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000225	0.0011	CbGpPWpGaD
Adinazolam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000224	0.0011	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000223	0.0011	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—JUN—kidney cancer	0.000223	0.0011	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000222	0.00109	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000222	0.00109	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—CTNNB1—kidney cancer	0.000222	0.00109	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000221	0.00108	CbGpPWpGaD
Adinazolam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00022	0.00108	CbGpPWpGaD
Adinazolam—GABRR1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000219	0.00108	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000218	0.00107	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000216	0.00106	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—BRAF—kidney cancer	0.000215	0.00106	CbGpPWpGaD
Adinazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000213	0.00105	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000213	0.00105	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—BRAF—kidney cancer	0.000212	0.00104	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000211	0.00104	CbGpPWpGaD
Adinazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000211	0.00104	CbGpPWpGaD
Adinazolam—GABRR2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000209	0.00103	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000205	0.00101	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000202	0.000995	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000202	0.000992	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000202	0.000991	CbGpPWpGaD
Adinazolam—GABRA1—Ion channel transport—RAF1—kidney cancer	0.0002	0.000983	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000198	0.000974	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000197	0.000968	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000196	0.000964	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000195	0.000958	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—BRAF—kidney cancer	0.000194	0.000953	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000193	0.00095	CbGpPWpGaD
Adinazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000193	0.000948	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000193	0.000947	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—RAF1—kidney cancer	0.000192	0.000946	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—RAF1—kidney cancer	0.000189	0.000932	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000189	0.000931	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000189	0.00093	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—BRAF—kidney cancer	0.000188	0.000926	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000188	0.000924	CbGpPWpGaD
Adinazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000187	0.000921	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000186	0.000914	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—BRAF—kidney cancer	0.000185	0.00091	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000185	0.000907	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MAPK3—kidney cancer	0.000185	0.000907	CbGpPWpGaD
Adinazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000184	0.000904	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTP1—kidney cancer	0.000183	0.000899	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000183	0.000899	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000183	0.000898	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—BRAF—kidney cancer	0.000182	0.000894	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000182	0.000893	CbGpPWpGaD
Adinazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000181	0.000889	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—BRAF—kidney cancer	0.000181	0.000888	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	0.00018	0.000887	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00018	0.000887	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00018	0.000885	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	0.00018	0.000884	CbGpPWpGaD
Adinazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.00018	0.000883	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—RAF1—kidney cancer	0.000179	0.000882	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000178	0.000877	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000178	0.000876	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—BRAF—kidney cancer	0.000177	0.000872	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—RAF1—kidney cancer	0.000177	0.00087	CbGpPWpGaD
Adinazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000176	0.000867	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MAPK1—kidney cancer	0.000176	0.000863	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000172	0.000847	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00017	0.000838	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.00017	0.000834	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000169	0.000831	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000168	0.000827	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTM1—kidney cancer	0.000168	0.000826	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—MAPK1—kidney cancer	0.000168	0.000826	CbGpPWpGaD
Adinazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000166	0.000816	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	0.000166	0.000815	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—RAF1—kidney cancer	0.000162	0.000796	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000161	0.000793	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.00016	0.000789	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—MAPK1—kidney cancer	0.00016	0.000788	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	0.000159	0.000783	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	0.000159	0.00078	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000158	0.000779	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—RAF1—kidney cancer	0.000157	0.000773	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	0.000157	0.000773	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000157	0.000772	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000156	0.000766	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—BRAF—kidney cancer	0.000155	0.000762	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—RAF1—kidney cancer	0.000154	0.000759	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000154	0.000758	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000154	0.000757	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—RAF1—kidney cancer	0.000152	0.000746	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—RAF1—kidney cancer	0.000151	0.000741	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000149	0.000735	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	0.000149	0.000731	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—RAF1—kidney cancer	0.000148	0.000728	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000147	0.000722	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000145	0.000713	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000144	0.000709	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000143	0.000705	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000141	0.000692	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000141	0.000692	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ACY1—kidney cancer	0.00014	0.000689	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000138	0.00068	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000136	0.000668	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000135	0.000664	CbGpPWpGaD
Adinazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000134	0.000661	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000133	0.000652	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—MAPK1—kidney cancer	0.000132	0.000649	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000132	0.000647	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—MAPK1—kidney cancer	0.00013	0.000639	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—RAF1—kidney cancer	0.000129	0.000636	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000126	0.000618	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000123	0.000605	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—MAPK1—kidney cancer	0.000123	0.000605	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—MAPK1—kidney cancer	0.000121	0.000597	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00012	0.000588	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PDHB—kidney cancer	0.000119	0.000586	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—POMC—kidney cancer	0.000119	0.000584	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000116	0.00057	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CCBL1—kidney cancer	0.000112	0.000551	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—MAPK1—kidney cancer	0.000111	0.000546	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	0.00011	0.000541	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	0.000108	0.000533	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—MAPK1—kidney cancer	0.000108	0.00053	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—MAPK1—kidney cancer	0.000106	0.000521	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—MAPK1—kidney cancer	0.000104	0.000512	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—MAPK1—kidney cancer	0.000103	0.000509	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000103	0.000509	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000102	0.000501	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—MAPK1—kidney cancer	0.000102	0.000499	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000101	0.000498	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	0.000101	0.000497	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	9.97e-05	0.00049	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PPAT—kidney cancer	9.71e-05	0.000478	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GLIPR1—kidney cancer	9.71e-05	0.000478	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—RAF1—kidney cancer	9.64e-05	0.000474	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	9.59e-05	0.000472	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	9.58e-05	0.000471	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—RAF1—kidney cancer	9.52e-05	0.000468	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	9.49e-05	0.000467	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	9.45e-05	0.000465	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—APRT—kidney cancer	9.03e-05	0.000444	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—FH—kidney cancer	9.03e-05	0.000444	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—MAPK1—kidney cancer	8.88e-05	0.000437	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.83e-05	0.000434	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.7e-05	0.000428	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GPC3—kidney cancer	8.49e-05	0.000417	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—RAF1—kidney cancer	8.46e-05	0.000416	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ACY1—kidney cancer	8.43e-05	0.000414	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—RAF1—kidney cancer	8.3e-05	0.000408	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CA2—kidney cancer	8.26e-05	0.000406	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.16e-05	0.000401	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—RAF1—kidney cancer	8.11e-05	0.000399	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ALAD—kidney cancer	8.05e-05	0.000396	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—RAF1—kidney cancer	7.96e-05	0.000391	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ST3GAL2—kidney cancer	7.86e-05	0.000386	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ALDH1A1—kidney cancer	7.68e-05	0.000378	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PGK1—kidney cancer	7.36e-05	0.000362	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC5A3—kidney cancer	7.36e-05	0.000362	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—LDHB—kidney cancer	7.22e-05	0.000355	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PDHB—kidney cancer	7.17e-05	0.000352	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—POMC—kidney cancer	7.14e-05	0.000351	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.96e-05	0.000342	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CCBL1—kidney cancer	6.74e-05	0.000331	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CA9—kidney cancer	6.26e-05	0.000308	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.12e-05	0.000301	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GLIPR1—kidney cancer	5.84e-05	0.000287	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PPAT—kidney cancer	5.84e-05	0.000287	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—APRT—kidney cancer	5.43e-05	0.000267	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—FH—kidney cancer	5.43e-05	0.000267	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CRABP1—kidney cancer	5.32e-05	0.000262	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GPC3—kidney cancer	5.11e-05	0.000251	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CA2—kidney cancer	4.97e-05	0.000244	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ITPR2—kidney cancer	4.95e-05	0.000243	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ALAD—kidney cancer	4.84e-05	0.000238	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.72e-05	0.000232	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.62e-05	0.000227	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.56e-05	0.000224	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTT1—kidney cancer	4.51e-05	0.000222	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ACHE—kidney cancer	4.51e-05	0.000222	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PGK1—kidney cancer	4.43e-05	0.000218	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.43e-05	0.000218	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—LDHB—kidney cancer	4.34e-05	0.000213	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SCARB1—kidney cancer	4.27e-05	0.00021	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTGS1—kidney cancer	4.23e-05	0.000208	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PSMD7—kidney cancer	4.15e-05	0.000204	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—BCHE—kidney cancer	3.93e-05	0.000193	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.88e-05	0.000191	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CA9—kidney cancer	3.76e-05	0.000185	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.75e-05	0.000184	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.64e-05	0.000179	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CRABP1—kidney cancer	3.2e-05	0.000157	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.17e-05	0.000156	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTP1—kidney cancer	3.13e-05	0.000154	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ITPR2—kidney cancer	2.98e-05	0.000146	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ABCB1—kidney cancer	2.96e-05	0.000146	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTM1—kidney cancer	2.87e-05	0.000141	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.72e-05	0.000134	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTT1—kidney cancer	2.71e-05	0.000133	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ACHE—kidney cancer	2.71e-05	0.000133	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SCARB1—kidney cancer	2.57e-05	0.000126	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTGS1—kidney cancer	2.54e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PSMD7—kidney cancer	2.49e-05	0.000123	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—BCHE—kidney cancer	2.36e-05	0.000116	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.33e-05	0.000115	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.25e-05	0.000111	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.24e-05	0.00011	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—POMC—kidney cancer	2.03e-05	9.99e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTP1—kidney cancer	1.88e-05	9.25e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ABCB1—kidney cancer	1.78e-05	8.75e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTM1—kidney cancer	1.73e-05	8.5e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.64e-05	8.06e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTGS2—kidney cancer	1.62e-05	7.97e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTEN—kidney cancer	1.41e-05	6.95e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—POMC—kidney cancer	1.22e-05	6.01e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CA—kidney cancer	9.97e-06	4.9e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTGS2—kidney cancer	9.74e-06	4.79e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTEN—kidney cancer	8.5e-06	4.18e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.99e-06	2.95e-05	CbGpPWpGaD
